ICE Japan – ICE Pharma Group

ICE Pharma Group is a global company with more than 70 years of history, providing products and services to the pharmaceutical and healthcare markets. Founded in 1949 in Northern Italy by Dr. Walter and Ida Bartoli, the company has expanded its business through both organic growth and strategic acquisitions under the leadership of Enzo Bartoli.

Today, the Group has established a global manufacturing and commercial network across North and South America, Europe, Asia, and Oceania, serving customers in more than 50 countries. Since 2019, ICE Pharma has been part of Advent International, one of the world’s leading private equity firms, which has further accelerated its growth.

Through a series of strategic acquisitions, the Group has evolved into a global organization with seven interconnected manufacturing sites. ICE Pharma Group has established itself as a global leader in bile acid derivative-based products, including Ursodeoxycholic Acid (UDCA). With decades of expertise and a strong commitment to quality, we are recognized as a reliable and trusted supplier to the pharmaceutical industry.

In addition to API supply, we offer a broad portfolio of products, including excipients, cell culture media for diagnostics, GMP intermediates, and research chemicals. Our services also include contract manufacturing (CMO) for both solid and liquid dosage forms. Furthermore, we manufacture and commercialize branded products in the pharmaceutical, nutraceutical, and cosmetics markets.